Synthetic human pancreatic GH-releasing factor (1\p=n-\44)NH2 (GRF) and acetylcholine (ACh) were shown to evoke a dose-related release of GH from cultured bovine pituitary cells with half-maximal effective doses of 0\m=.\3and 500 nmol/l respectively. 
INTRODUCTION
The 44 amino acid peptide, growth hormone-releasing factor(l-44)NH2 (GRF) , specifically stimulates the secretion of growth hormone (GH) in a number of species including cattle (Moseley, Krabill, Friedman & Olsen, 1984 (Vale, Vaughan, Smith et al. 1983) .
Bovine somatotrophs appear to possess receptors for thyrotrophin-releasing hormone (TRH) , bombesin (Bicknell & Chapman, 1983) and acetylcholine (ACh) (Young, Bicknell & Schofield, 1979) since these factors can elicit secretion of GH in vitro. Although there is now a well-established role for TRH in the stimulation of both thyrotrophin and prolactin release (Naor, Snyder, Fawcett & McCann, 1980; Becu & Libertun, 1982) , the physiological function it has in regulating GH secretion is uncertain. Injection of TRH into both rats (Takahara, Arimura & Schally, 1974) and cattle (Convey, Tucker, Smith & Zolman, 1973) . A similar uncertainty exists for the role of bombesin-related peptides. Bombesin-like immuno¬ reactivity has been localized in high concentrations in the mammalian hypothalamus (Villarreal & Brown, 1978; Moody, O'Donohue & Jacobwitz, 1981) , and the demonstration that it is released from hypo¬ thalamic nerve endings (Moody, Thoa, O'Donohue & Pert, 1980) suggests that it may have a hypophysio¬ trophic function. Injection of bombesin into rats has been shown to stimulate the release of GH and pro¬ lactin (Rivier, Rivier & Vale, 1978) Mukherjee, Snyder & McCann, 1980) , but it appears to have a species-specific effect on prolactin release; inhibitory in rat (Mukherjee et al. 1980 ; Rudnick & Dannies, 1981) and stimulatory in cattle (Bicknell & Chapman, 1983) . Whether ACh has a physiological regulatory role in the anterior pituitary is unknown (see Discussion).
In the present work we have investigated the possible interactions of ACh, bombesin and TRH with the GHspecific releasing factor GRF, on GH and prolactin secretion from cultures of the bovine pituitary.
MATERIALS AND METHODS

Cell cultures
Cells were prepared from anterior pituitaries of steers by enzymic dispersion using collagenase as previously described (Bicknell & Chapman, 1983 (Bicknell & Chapman, 1983) . Mean intra-assay coefficients of variation were 8-2 and 5-4% for GH and prolactin respectively. (a) human pancreatic GH-releasing factor(l^l4)NH2 (GRF) and (b) Figure lb shows the response of similar cultures to increasing concentrations of ACh in the presence of the cholinesterase inhibitor, eserine sulphate (5 pmol/1). Significant stimulation of both GH and prolactin release was observed at 01 pmol ACh/1 (the lowest concentration tested) and, for both hormones, the EC50 value was near to 0-5 pmol/1. In three separate experiments the effect of 10 pmol ACh/1 was abolished by addition of the muscarinic antagonist, atropine (Fig. Ic) .
In all the experiments reported, the relative maxi¬ mal stimulation of GH and prolactin release was variable, but generally ACh was either equipotent or more effective for GH release. In no culture was a significantly greater stimulation of prolactin observed.
Combined effects of GRF and ACh
Concentrations of GRF (25 nmol/1) and ACh (10 pmol/1) which were shown to produce a near maxi¬ mal response ( Fig. 1 and Bicknell & Chapman, 1983) , elicited highly significant increases in GH secretion (Fig. 2a) . When presented simultaneously the GH response was both significantly ANOVA) atropine (Fig. 2b) . In a separate experiment the GH response to GRF was shown to be unaffected by the presence of 5 pmol eserine/1 (data not shown).
Although prolactin release in these experiments was significantly increased by ACh, GRF had no modifying effect on either basal or ACh-stimulated release ( Fig.  2a and b) .
Combined effects of GRF and TRH Figure 3a shows the effect of GRF (25 nmol/1) and TRH (1 pmol/1) on GH and prolactin release from pituitary cultures. As in Figs 1 and 2, GRF caused a marked stimulation of GH release but had no effect on prolactin release. Thyrotrophin-releasing hormone, on the other hand, caused release of pro¬ lactin but had no significant effect on GH. When presented in combination, prolactin release was not modified from that caused by TRH alone, but GH release was significantly increased above that pro¬ duced by GRF (Fig. 3a) . In addition, this response to combined TRH and GRF was significantly (P< 0-001; ANOVA) greater than the sum of the individual responses. In a further two experiments the concentration dependence of the TRH synergism was investigated (Fig. 3b) . At concentrations above 10 nmol TRH/1 the GH response was significantly above that obtained with GRF alone. At 1 nmol/1, TRH had no effect on GRF-induced GH release, although it still had a significant effect on prolactin release. Maximum responses were seen at 0-1 pmol/1, although the responses to both peptides were less than those seen in Fig. 3a (Bicknell & Chapman, 1983) , challenge of pituitary cell cultures with bombesin (0-1 pmol/1) had only a small and not significant (P approx. 0-07; ANOVA) effect on basal GH release. However, when given simultaneously with GRF, bombesin markedly potentiated the GH release induced by GRF (Fig. 5a ). Neither GRF nor bombesin had any significant effect on prolactin release. This effect was specific for GRF since bombesin had no significant effect when given in combination with ACh (Fig. 5b) (LaBella & Shin, 1968) and rats (Barron & Hoover, 1983) , the degrading enzyme acetylcholinesterase, has been detected in the anterior pituitary. Neither of these studies could detect significant levels of the ACh synthesis enzyme, cholineacetyltransferase. In addition, atropine-sensitive binding of the muscarinic antagonist, [3H] quinuclidinyl benzilate has been demonstrated in the sheep (Burt & Taylor, 1980) and rat (Mukherjee et al. 1980; Schaeffer & Hsueh, 1980) The direct action of ACh on hormone secretion has been tested using in-vitro pituitary preparations. In rat-derived tissue, cholinergic agonists are either ineffective (Campbell, Jacques & Gala, 1978) or inhibitory (Mukherjee et al. 1980 ; Rudnick & Dannies, 1981) to prolactin secretion, while the effect is stimulatory in bovine tissue (Bicknell & Chapman, 1983) . However, in the case of both species, where examined, the effect of ACh on GH secretion is stimulatory. The present results clearly support a role for ACh in stimulating both prolactin and GH release from bovine pituitary cells. In both cases EC50 values were about 0-50 pmol/1 and the effects were mediated through a muscarinic receptor, as previously described (Young et al. 1979; Bicknell & Chapman, 1983) .
It is presently uncertain whether the bombesin immunoreactivity detected in the mammalian hypothalamus is native bombesin or the structur¬ ally related gastrin-releasing peptide (McDonald, Jornvall, Nilsson et al. 1979) . The role of these bombesin-like peptides is also uncertain, although studies on bovine pituitary cell cultures (Bicknell & Chapman, 1983) and the rat pituitary 4^c ell line (Westendorf & Schonbrunn, 1982) (Bilezikjian & Vale, 1983) . In contrast, the action of ACh on bovine pituitary cells has been shown to involve an increase in membrane phosphatidylinositol (PI) turnover and 45Ca2+ efflux and, while cGMP levels are increased, there is no effect on cAMP (Young et al. 1979) . A similar group of responses has been reported for the action of TRH on rat GH3 pituitary cell cultures (Gautvik, Haug & Kriz, 1978; Gershengorn, 1980; Rebecchi, Monaco & Gershengorn, 1981) and for bombesin on rat pan¬ creatic acinar cells (May, Conlon, Erspamer & Gardner, 1978 (Ohmura, Tsushima, Murakami et al. 1984) . The action of phorbol esters is believed to be by substitution for diacylglycerol, normally formed during receptor-mediated PI turnover, and by directly activating Ca2+-activated phospholipid-dependent protein kinase C (Castagna, Takai, Kaibuchi et al. 1982) . Recently it has been demonstrated that both GRF and cAMP have a synergistic effect on phorbol ester-induced rat GH release (Ohmura & Friesen, 1985) , suggesting that they are acting through separate pathways.
The type of synergistic interactions described here have been reported for a number of receptor-mediated endocrine responses (Gardner & Jensen, 1980; , and may be an important physiological mechanism for increasing both the specificity and magnitude of the responses. The specificity of effect of GRF and its synergistic interaction with other hypothalamic factors, including TRH (Borges, Uskavitch, Kaiser et al. 1983; Leung & Taylor, 1983), vasopressin and PHI(l-27) (Vigh & Schally, 1984) as well as those reported here, suggests that it may act in concert with these factors to regulate GH secretion from the anterior pituitary. It is possible that a number of in-vivo effects, including those of bombesin (Rivier et al. 1978) and TRH (Convey et al. 1973; Takahara et al. 1974) , may be explained in terms of such a synergistic interaction.
